Rheumatoid arthritis: Disease or syndrome?
Jessica A Stanich1, John D Carter2, Judith Whittum-Hudson1, Alan P Hudson11Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI, USA; 2Division of Rheumatology, Department of Internal Medicine, University of South Florida School of Medicine, Tampa, FL, US...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2009
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/d2efbda7196d44a5ab6f83f35c62930b |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Jessica A Stanich1, John D Carter2, Judith Whittum-Hudson1, Alan P Hudson11Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI, USA; 2Division of Rheumatology, Department of Internal Medicine, University of South Florida School of Medicine, Tampa, FL, USAAbstract: Rheumatoid arthritis (RA) has been described in the medical literature for over two hundred years, but its etiology remains unknown. RA displays phenotypic heterogeneity, and it is a relatively prevalent clinical entity: it affects approximately 1% of the population, resulting in enormous pathologic sequelae. Earlier studies targeting the cause(s) of RA suggested potential infectious involvement, whereas more recent reports have focused on a genetic origin of the disease. However, neither infection nor genetics, nor any other single factor is currently accepted as causative of RA. In this article we review studies relating to the etiology of RA, and those of several related matters, and we conclude that the literature indeed does provide insight into the causes underlying the initiation of RA pathogenesis. Briefly, given the remarkable phenotypic variation of RA, especially in its early stages, as well as a number of other characteristics of the condition, we contend that RA is not a discrete clinical entity with a single etiological source. Rather, we argue that it represents a common clinical endpoint for various starting points, each of which is largely guided by as yet poorly understood aspects of the genetic background of the affected individual. Adoption of this alternative view of the origin of RA will have significant consequences for future research and for development of new therapeutic interventions for this burdensome condition.Keywords: rheumatoid arthritis pathogenesis etiologic studies genetic background |
|---|